Company Filing History:
Years Active: 2013
Title: The Innovations of Matthew Walker
Introduction
Matthew Walker is an accomplished inventor based in Ventura, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target beta-secretase activity. His work is particularly relevant for the treatment of Alzheimer's disease and other central nervous system conditions.
Latest Patents
Matthew Walker holds a patent for "Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use." This invention comprises a new class of compounds that modulate beta-secretase activity, which is crucial for treating diseases such as Alzheimer's disease. The patent outlines various formulas for these compounds, which can be utilized in pharmaceutical compositions to address disorders related to beta-secretase protein activity.
Career Highlights
Walker is associated with Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Amgen has allowed him to focus on developing therapeutic solutions that can significantly impact patients' lives.
Collaborations
Some of his notable coworkers include Wenge Zhong and Stephen A Hitchcock. Their collaborative efforts contribute to the advancement of research and development in the field of biotechnology.
Conclusion
Matthew Walker's innovative work in the pharmaceutical industry exemplifies the importance of research in combating neurological diseases. His contributions through patents and collaborations continue to pave the way for future advancements in medicine.